OPC Pharmaceutical JSC (HOSE:OPC)
23,500
0.00 (0.00%)
At close: May 21, 2026
OPC Pharmaceutical JSC Revenue
OPC Pharmaceutical JSC had revenue of 216.26B VND in the quarter ending March 31, 2026, with 2.75% growth. This brings the company's revenue in the last twelve months to 1.13T, up 17.84% year-over-year. In the year 2025, OPC Pharmaceutical JSC had annual revenue of 1.12T with 15.94% growth.
Revenue (ttm)
1.13T
Revenue Growth
+17.84%
P/S Ratio
1.33
Revenue / Employee
1.30B
Employees
871
Market Cap
1.51T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12T | 154.41B | 15.94% |
| Dec 31, 2024 | 968.58B | -36.31B | -3.61% |
| Dec 31, 2023 | 1.00T | -166.73B | -14.23% |
| Dec 31, 2022 | 1.17T | 47.89B | 4.26% |
| Dec 31, 2021 | 1.12T | 158.14B | 16.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.74T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Imexpharm | 2.39T |
| Domesco Medical Import - Export Joint-Stock | 2.12T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.31T |
| Vidipha Central Pharmaceutical JSC | 971.25B |
| Ben Tre Pharmaceutical JSC | 860.31B |